NASDAQ:NUWE - Nasdaq - US67113Y6032 - Common Stock - Currency: USD
Overall NUWE gets a fundamental rating of 3 out of 10. We evaluated NUWE against 187 industry peers in the Health Care Equipment & Supplies industry. While NUWE seems to be doing ok healthwise, there are quite some concerns on its profitability. NUWE is valied quite expensively at the moment, while it does show a decent growth rate.
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | -140.57% | ||
ROE | -274.93% | ||
ROIC | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
OM | N/A | ||
PM (TTM) | N/A | ||
GM | 63.18% |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 0 | ||
Debt/FCF | N/A | ||
Altman-Z | -62.65 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Current Ratio | 2.23 | ||
Quick Ratio | 1.59 |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | N/A | ||
Fwd PE | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
P/FCF | N/A | ||
EV/EBITDA | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | N/A |
NASDAQ:NUWE (6/25/2025, 3:42:40 PM)
0.2565
-0.01 (-4.96%)
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | N/A | ||
Fwd PE | N/A | ||
P/S | 0.13 | ||
P/FCF | N/A | ||
P/OCF | N/A | ||
P/B | 0.31 | ||
P/tB | 0.31 | ||
EV/EBITDA | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | -140.57% | ||
ROE | -274.93% | ||
ROCE | N/A | ||
ROIC | N/A | ||
ROICexc | N/A | ||
ROICexgc | N/A | ||
OM | N/A | ||
PM (TTM) | N/A | ||
GM | 63.18% | ||
FCFM | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 0 | ||
Debt/FCF | N/A | ||
Debt/EBITDA | N/A | ||
Cap/Depr | 10.1% | ||
Cap/Sales | 0.35% | ||
Interest Coverage | N/A | ||
Cash Conversion | N/A | ||
Profit Quality | N/A | ||
Current Ratio | 2.23 | ||
Quick Ratio | 1.59 | ||
Altman-Z | -62.65 |